Arbutus Biopharma market cap ABUS

Share price times shares outstanding: what the whole company sells for, since 2012.

Arbutus Biopharma is worth $831M at the close on Oct 23, 2026, at $4.20 a share.

That is down 1% over the last year and up 108% over five years.

Its highest close in our data was $1B in Aug 2026.

Market cap over time

Year	End of year	Low	High	Change
2026 so far	$831M	$738.5M	$1B	−10%
2025	$919.3M	$589.9M	$919.3M	+51%
2024	$608.3M	$387.4M	$859M	+45%
2023	$419.2M	$289.9M	$492.6M	+15%
2022	$364.6M	$286.4M	$473.4M	−31%
2021	$526.2M	$252.5M	$579M	+75%
2020	$301.4M	$62.7M	$369.4M	+113%
2019	$141.6M	$50M	$253.5M	−34%
2018	$215.3M	$194.7M	$644.1M	−23%
2017	$278M	$139.8M	$398.9M	+107%
2016	$134.4M	$134.4M	$291.2M	−45%
2015	$242.8M	$242.8M	$907.1M	−23%
2014	$315.9M	$111.6M	$652.8M	+184%
2013	$111.3M	$52.8M	$138.2M	+90%
2012	$58.4M	$23.7M	$63.4M	n/a

Companies in Drug Manufacturers - General nearest Arbutus Biopharma's size, closest first, today.

Company	Market cap
ABUSArbutus Biopharma	$831M
COLLCollegium Pharmaceutical	$747.5M
AMPHAmphastar Pharmaceuticals	$1.1B
CRMDCorMedix	$611.9M
ZVRAZevra Therapeutics	$582.6M
OMEROmeros	$1.2B
IRWDIronwood Pharmaceuticals	$571.7M
PBYIPuma Biotechnology	$568.9M
ARVNArvinas	$477.3M
PCRXPacira BioSciences	$1.5B
ANABAnaptysbio	$1.5B
Peer median	$679.7M